Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)
Clinical trial NCT02500901 · TERMINATED
Trial details
- NCT number
- NCT02500901
- Sponsor
- Paul Mathew, MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-05-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.